Dr. Ramchand is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-445-1382
Education & Training
University of Melbourne, AustraliaClass of 2008
Publications & Presentations
PubMed
- Skeletal effects of adjuvant zoledronic acid and its cessation in women with early-stage breast cancer.Sabashini K Ramchand
Journal of Bone and Mineral Research. 2024-09-02 - Correction to: The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.Sabashini K Ramchand, Joy N Tsai, Hang Lee, Grace Sassana-Khadka, Mackenzie Jordan
Osteoporosis International. 2024-02-01 - 4 citationsThe comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.Sabashini K Ramchand, Joy N Tsai, Hang Lee, Grace Sassana-Khadka, Mackenzie Jordan
Osteoporosis International. 2024-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
